IP Verse

Rsv F Protein Compositions And Methods For Making Same - EP4183412

The patent EP4183412 was granted to Glaxosmithkline on Aug 14, 2024. The application was originally filed on Jul 15, 2010 under application number EP22200670A. The patent is currently recorded with a legal status of "No Opposition Filed Within Time Limit".

EP4183412

GLAXOSMITHKLINE
Application Number
EP22200670A
Filing Date
Jul 15, 2010
Status
No Opposition Filed Within Time Limit
Jun 20, 2025
Publication Date
Aug 14, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Citations (109) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP20030291813
DESCRIPTIONGB20220020211
DESCRIPTIONWO1994US05700
DESCRIPTIONEP0109942
DESCRIPTIONEP0626169
DESCRIPTIONEP0787180
DESCRIPTIONFR2859633
DESCRIPTIONUS118
DESCRIPTIONUS119
DESCRIPTIONUS139
DESCRIPTIONUS2005070556
DESCRIPTIONUS2005192248
DESCRIPTIONUS2008057080
DESCRIPTIONUS2008085870
DESCRIPTIONUS4186745
DESCRIPTIONUS4666886
DESCRIPTIONUS4680338
DESCRIPTIONUS4689338
DESCRIPTIONUS4797368
DESCRIPTIONUS4929624
DESCRIPTIONUS4988815
DESCRIPTIONUS5011828
DESCRIPTIONUS5057540
DESCRIPTIONUS5173414
DESCRIPTIONUS5238944
DESCRIPTIONUS5266575
DESCRIPTIONUS5268376
DESCRIPTIONUS5279833
DESCRIPTIONUS5340740
DESCRIPTIONUS5346905
DESCRIPTIONUS5352784
DESCRIPTIONUS5389640
DESCRIPTIONUS5395937
DESCRIPTIONUS5397307
DESCRIPTIONUS5482936
DESCRIPTIONUS5494916
DESCRIPTIONUS5525612
DESCRIPTIONUS5547472
DESCRIPTIONUS5656479
DESCRIPTIONUS5658731
DESCRIPTIONUS5674192
DESCRIPTIONUS5830510
DESCRIPTIONUS5916588
DESCRIPTIONUS5936076
DESCRIPTIONUS6060308
DESCRIPTIONUS6071890
DESCRIPTIONUS6080725
DESCRIPTIONUS6083505
DESCRIPTIONUS6083741
DESCRIPTIONUS6090406
DESCRIPTIONUS6090619
DESCRIPTIONUS6114168
DESCRIPTIONUS6129705
DESCRIPTIONUS6207646
DESCRIPTIONUS6239116
DESCRIPTIONUS6355271
DESCRIPTIONUS6429199
DESCRIPTIONUS6440992
DESCRIPTIONUS6500668
DESCRIPTIONUS6586409
DESCRIPTIONUS6605617
DESCRIPTIONUS6627640
DESCRIPTIONUS6664264
DESCRIPTIONUS6664265
DESCRIPTIONUS6667312
DESCRIPTIONUS6677347
DESCRIPTIONUS6677348
DESCRIPTIONUS6677349
DESCRIPTIONUS6683088
DESCRIPTIONUS6703402
DESCRIPTIONUS6743920
DESCRIPTIONUS6800624
DESCRIPTIONUS6809203
DESCRIPTIONUS6888000
DESCRIPTIONUS6924271
DESCRIPTIONUS6924293
DESCRIPTIONWO0007621
DESCRIPTIONWO0023105
DESCRIPTIONWO0121152
DESCRIPTIONWO0121207
DESCRIPTIONWO0122972
DESCRIPTIONWO03043415
DESCRIPTIONWO03076601
DESCRIPTIONWO03105769
DESCRIPTIONWO2004060308
DESCRIPTIONWO2004064715
DESCRIPTIONWO2004064759
DESCRIPTIONWO2005042728
DESCRIPTIONWO2005097181
DESCRIPTIONWO2005102049
DESCRIPTIONWO2006011060
DESCRIPTIONWO2009111337
DESCRIPTIONWO2009132206
DESCRIPTIONWO9014837
DESCRIPTIONWO9106309
DESCRIPTIONWO9215582
DESCRIPTIONWO9324640
DESCRIPTIONWO9324641
DESCRIPTIONWO9511700
DESCRIPTIONWO9517211
DESCRIPTIONWO9611711
DESCRIPTIONWO9633739
DESCRIPTIONWO9842375
DESCRIPTIONWO9927960
DESCRIPTIONWO9952549
SEARCHWO03083095
SEARCHWO2009079796
SEARCHWO2010009277
SEARCHWO2010077717

Non-Patent Literature (NPL) Citations (120) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ADAMSON et al., Curr Opin Biotechnol, (19930000), vol. 4, pages 428 - 347
DESCRIPTION- AKDIS et al., Eur. J. Immunology, (20030000), vol. 33, pages 2717 - 26
DESCRIPTION- ALI et al., Gene Ther, (19940000), vol. 1, pages 367 - 384
DESCRIPTION- ALLISONBYARS, Res Immunol, (19920000), vol. 143, pages 519 - 25
DESCRIPTION- ANDRIANOV et al., Biomaterials, (19980000), vol. 19, pages 109 - 115
DESCRIPTION- ARNDT et al., Structure, (20020000), vol. 10, pages 1235 - 1248
DESCRIPTION- BALDRICK et al., Regulatory Toxicol Pharmacol, (20020000), vol. 35, pages 398 - 413
DESCRIPTION- BASCHANG et al., Tetrahedron, (19890000), vol. 45, no. 20, pages 6331 - 6360
DESCRIPTION- BECKBRODSKY, J Struct Biol, (19980000), vol. 122, pages 17 - 29
DESCRIPTION- BEMBRIDGE et al., J Virol, (19990000), vol. 73, pages 10086 - 10094
DESCRIPTION- BERNS et al., Ann. NY Acad. Sci, (19950000), vol. 772, pages 95 - 104
DESCRIPTION- BLACKWELL et al., J Immunol, (20030000), vol. 170, pages 4061 - 4068
DESCRIPTION- BUCHSCHER et al., J. Virol., (19920000), vol. 66, no. 5, pages 2731 - 2739
DESCRIPTION- BURKHARD et al., Trends Cell Biol, (20010000), vol. 11, pages 82 - 88
DESCRIPTION- CHAO et al., J Chromatog B Biomed Sci Appl, (19980000), vol. 715, pages 307 - 329
DESCRIPTION- CHEN et al., J Virol, (20040000), vol. 78, pages 4508 - 16
DESCRIPTION- COOPER, Pharm Biotechnol, (19950000), vol. 6, pages 559 - 80
DESCRIPTION- CORPET, Nucleic Acids Research, (19980000), vol. 16, no. 22, pages 10881 - 10890
DESCRIPTION- CREIGHTON, Proteins, ISBN 0-7167-2317-4
DESCRIPTION- CURIEL et al., Proc. Natl. Acad. Sci. USA, (19910000), vol. 88, page 8850
DESCRIPTION- DE LIBERO et al., Nature Reviews Immunology, (20050000), vol. 5, pages 485 - 496
DESCRIPTION- DYAKONOVA et al., Int Immunopharmacol, (20040000), vol. 4, no. 13, pages 1615 - 23
DESCRIPTION- FELGNER et al., Proc. Natl. Acad. Sci. USA, (19870000), vol. 84, pages 7413 - 7414
DESCRIPTION- "Functional Polymer Colloids and Microparticles", Microspheres, microcapsules & liposomes, Citus Books, (20020000), vol. 4
DESCRIPTION- GARDNERDUTCH, J Virol, (20070000), vol. 8, no. 1, pages 8303 - 14
DESCRIPTION- "GenBank GI", Database accession no. 138251
DESCRIPTION- GOFFET et al., Am Chem Soc, (20040000), vol. 126, pages 13602 - 13603
DESCRIPTION- GONZALEZ-REYES et al., Proc. Natl. Acad. Sci. USA, (20010000), vol. 98, pages 9859 - 9864
DESCRIPTION- GREENBAUM et al., Vaccine, (20040000), vol. 22, pages 2425 - 77
DESCRIPTION- HADDADA et al., Curr. Top. Microbiol. Immunol, (19950000), pages 297 - 306
DESCRIPTION- HALPERIN et al., Am J Public Health, (19790000), vol. 69, pages 1247 - 50
DESCRIPTION- HANTKE et al., Eur. J Biochem, (19730000), vol. 34, pages 284 - 296
DESCRIPTION- HARBURY et al., Science, (19930000), vol. 262, pages 1401 - 1407
DESCRIPTION- HARIHARAN et al., Cancer Res, (19950000), vol. 55, pages 3486 - 9
DESCRIPTION- HERBERT et al., J Infect Dis, (19790000), vol. 140, pages 234 - 8
DESCRIPTION- HERMONATMUZYCZKA, Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 6466 - 6470
DESCRIPTION- HEYES et al., J Controlled Release, (20050000), vol. 107, pages 276 - 287
DESCRIPTION- I. BORG et al., Eur Respir J, (20030000), vol. 21, pages 944 - 51
DESCRIPTION- JOHANN et al., J. Virol, (19920000), vol. 66, no. 5, pages 1635 - 1640
DESCRIPTION- JOHNSON et al., BioorgMed Chem Lett, (19990000), vol. 9, pages 2273 - 2278
DESCRIPTION- JOHNSON et al., J Med Chem, (19990000), vol. 42, pages 4640 - 9
DESCRIPTION- JONES, Curr Opin Investig Drugs, (20030000), vol. 4, pages 214 - 218
DESCRIPTION- KAMMERER, Matrix Biol, (19970000), vol. 15, pages 555 - 568
DESCRIPTION- KANDIMALLA et al., BBRC, (20030000), vol. 300, pages 853 - 861
DESCRIPTION- KANDIMALLA et al., Biochemical Society Transactions, (20030000), vol. 31, pages 654 - 658
DESCRIPTION- KANDIMALLA et al., Nucleic Acids Research, (20030000), vol. 31, pages 2393 - 2400
DESCRIPTION- KIM et al., J Med Virol, (20070000), vol. 79, pages 820 - 828
DESCRIPTION- KOTIN, Human Gene Therapy, (19940000), vol. 5, pages 793 - 801
DESCRIPTION- KRIEG, Nature Medicine, (20030000), vol. 9, pages 831 - 835
DESCRIPTION- KRIEG, Trends Immunol, (20020000), vol. 23, pages 64 - 65
DESCRIPTION- LI et al., J Exp Med, (19980000), vol. 188, pages 681 - 688
DESCRIPTION- "Liposomes: Methods and Protocols", Pharmaceutical Nanocarriers: Methods and Protocol, Humana Press, (20090000), vol. 1
DESCRIPTION- LIULU, J Biol Chem, (20020000), vol. 277, pages 48708 - 48713
DESCRIPTION- LUPAS, Trends Biochem Sci, (19960000), vol. 21, pages 375 - 382
DESCRIPTION- MANNINOGOULD-FOGERITE, BioTechniques, (19880000), vol. 6, no. 7, pages 682 - 691
DESCRIPTION- MCCLUSKIE et al., FEMS Immunology and Medical Microbiology, (20020000), vol. 32, pages 179 - 185
DESCRIPTION- MCLAUGHLINSAMULSKI et al., J. Virol, (19880000), vol. 63, pages 03822 - 3828
DESCRIPTION- MERALDI et al., Vaccine, (20030000), vol. 21, pages 2485 - 249 1
DESCRIPTION- MILLER et al., J. Virol, (19910000), vol. 65, pages 2220 - 2224
DESCRIPTION- MULLER et al., Methods Knzymol, (20000000), vol. 328, pages 261 - 282
DESCRIPTION- MUZYCZKA, J. Clin. Invst., (19940000), vol. 94, page 1351
DESCRIPTION- MYERS et al., Cellular and molecular aspects of endotoxin reactions, (19900000), pages 145 - 156
DESCRIPTION- NONY et al., Vaccine, (20010000), vol. 19, pages 2673 - 2680
DESCRIPTION- O'HAGAN et al., J Virology, (20010000), vol. 75, pages 9037 - 9043
DESCRIPTION- OLD et al., J Clin Investig, vol. 113, pages 1631 - 1640
DESCRIPTION- OTT et al., Journal of Controlled Release, (20020000), vol. 79, no. 1-3, pages 1 - 5
DESCRIPTION- PAYNE et al., Adv Drug Delivery Review, (19980000), vol. 31, pages 185 - 196
DESCRIPTION- PIASCIK, J Am Pharm Assoc (Wash DC), (20030000), vol. 43, pages 728 - 30
DESCRIPTION- PIZZA et al., Int J Med Microbiol, (20000000), vol. 290, pages 455 - 461
DESCRIPTION- RUIZ-ARGUELLO et al., J. Gen. Virol., (20040000), vol. 85, page 3677687
DESCRIPTION- RUIZ-ARGUELLO et al., J. Gen. Virol, (20040000), vol. 85, pages 3677 - 3687
DESCRIPTION- SIGNORELLIHADDEN, Intlmmunopharmacol, (20030000), vol. 3, no. 8, pages 1177 - 86
DESCRIPTION- SINGH et al., J Cont Release, (20010000), vol. 70, pages 267 - 276
DESCRIPTION- SINGH et al., Pharmaceutical Research, (20030000), vol. 20, pages 247 - 251
DESCRIPTION- SJOLANDERET et al., Advanced Drug Delivery Reviews, (19980000), vol. 32, pages 321 - 338
DESCRIPTION- SLOVIC et al., Protein Sci, (20030000), vol. 12, pages 337 - 348
DESCRIPTION- SNELL et al., Virus Genes, (19970000), vol. 14, pages 63 - 72
DESCRIPTION- SOMMERFELT et al., Virol, (19900000), vol. 176, pages 58 - 59
DESCRIPTION- STANLEY, Clin Exp Dermatol, (20020000), vol. 27, no. 57, pages 1 - 577
DESCRIPTION- STEVENS et al., Science, (20040000), vol. 303, pages 1866 - 70
DESCRIPTION- SUMMERSSMITH, Texas Agricultural Experiment Station Bulletin, (19870000), no. 1555
DESCRIPTION- TASSIGNON et al., J Immunol Meth, (20050000), vol. 305, pages 188 - 98
DESCRIPTION- THOMPSON et al., Methods in Molecular Medicine, (20030000), vol. 94, pages 255 - 266
DESCRIPTION- TRATSCHIN et al., Mol. Cell. Biol, (19840000), vol. 4, pages 2072 - 2081
DESCRIPTION- TRATSCHIN et al., Mol. Cell. Biol, (19850000), vol. 5, no. 11, pages 3251 - 3260
DESCRIPTION- Vaccine, (20090000), vol. 27, pages 4975 - 4982
DESCRIPTION- "Vaccine Adjuvants: Preparation Methods and Research Protocols", Methods in Molecular Medicine series, vol. 42
DESCRIPTION- VASILAKOS et al., Cell Immunol, (20000000), vol. 204, no. 1, pages 64 - 74
DESCRIPTION- WEST et al., Virology, (19870000), vol. 160, pages 38 - 47
DESCRIPTION- WILSON et al., J. Virol, (19890000), vol. 63, pages 2374 - 2378
DESCRIPTION- WONG et al., J Clin Pharmacol, (20030000), vol. 43, no. 7, pages 735 - 42
DESCRIPTION- WU et al., Antiviral Res, (20040000), vol. 64, no. 2, pages 79 - 83
DESCRIPTION- WUWU, J. Biol. Chem., (19880000), vol. 263, page 14621
DESCRIPTION- YANG et al., Angew Chem Int, (20040000), vol. 43, pages 3818 - 3822
DESCRIPTION- YANG, J Virol, (20020000), vol. 76, pages 4634 - 42
DESCRIPTION- YIN et al., Nature, (20060000), vol. I-II-III, pages 38 - 45
DESCRIPTION- YIN et al., Proc Natl Acad Sci USA., (20050000), vol. 102, no. 26, pages 9288 - 93
DESCRIPTION- YU, Adv Drug Deliv Rev, (20020000), vol. 54, pages 1113 - 1129
DESCRIPTION- ZHANGCHEN, J Biol Chem, (19990000), vol. 274, pages 22409 - 22413
DESCRIPTION- ZURBRIGGEN et al., Expert Rev Vaccines, (20030000), vol. 2, pages 219 - 229
DESCRIPTION- HEYES, J.PALMER, LBREMNER, KMACLACHLAN, I, "Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids", Journal of Controlled Release, (20050000), vol. 107, doi:10.1016/j.jconrel.2005.06.014, pages 276 - 287, XP005076220
DESCRIPTION- PERRI SGREER CETHUDIUM KDOE BLEGG HLIU HROMERO RETANG ZBIN QDUBENSKY TW, JR et al., "An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector", J Virol, (20030000), vol. 77, doi:10.1128/JVI.77.19.10394-10403.2003, pages 10394 - 10403, XP002422501
DESCRIPTION- THOMPSON et al., "The low-toxicity versions of LPS MPLⓇ adjuvant and RC529, are efficient adjuvants for CD4+ T cells", JLeukoc Biol, (20050000), vol. 78, doi:10.1189/jlb.0305172, XP009063438
EXAMINATION- Bakkers Mark ET AL, "Addition of a trimerization domain (e.g. foldon) to a soluble RSV F protein", (20191021), URL: https://register.epo.org/application?documentId=LPCHWRVAZGV6M3L&number=EP22200670&lng=en&npl=false, XP093107398
EXAMINATION- Bakkers Mark, "Study Report Characterization of EP3178490 designs", (20230119), URL: https://register.epo.org/application?documentId=LD3C4IAI1COLM19&number=EP16190004&lng=en&npl=false, XP093047076
EXAMINATION- Bottomley Matthew James, "Declaration", (20170816), URL: https://register.epo.org/application?documentId=LNIRHHZLA2GD5BU&number=EP22200670&lng=en&npl=false, XP093107395
EXAMINATION- CHE YE ET AL, "Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine", SCIENCE TRANSLATIONAL MEDICINE, (20230426), vol. 15, no. 693, doi:10.1126/scitranslmed.ade6422, ISSN 1946-6234, XP093107400
EXAMINATION- CHE YE ET AL, "Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine- Supplementary Materials", SCIENCE TRANSLATIONAL MEDICINE, (20230426), vol. 15, no. 693, doi:10.1126/scitranslmed.ade6422, ISSN 1946-6234, XP093107504
EXAMINATION- Paul André, "Untersuchung der Bindungseigenschaft des Fusionsproteins des respiratorischen Synzytialvirus", (20090709), URL: https://www.repo.uni-hannover.de/handle/123456789/7323, XP093122470
SEARCH- ZIMMER GERT ET AL, "Cleavage at the furin consensus sequence RAR/KR109 and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture", 20020901, (20020901), vol. 76, no. 18, pages 9218 - 9224, XP009002025 [A] 1-9 * page 9222, column r * * page 9223; figures 1-4 *
SEARCH- LAMB ET AL, "Structural basis of viral invasion: lessons from paramyxovirus F", CURRENT OPINION IN STRUCTURAL BIOLOGY, ELSEVIER LTD, GB, (20070801), vol. 17, no. 4, doi:10.1016/J.SBI.2007.08.016, ISSN 0959-440X, pages 427 - 436, XP022273654 [A] 1-9 * the whole document *
SEARCH- KRARUP A ET AL, "A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism", NATURE COMMUNICATIONS, NATURE PUBLISHING GROUP, UNITED KINGDOM, vol. 6, doi:10.1038/NCOMMS9143, ISSN 2041-1723, (20150903), pages 8143 - 1, (20150903), XP002755858 [T] 1-9 * the whole document *
SEARCH- MCLELLAN JASON S ET AL, "Structural basis of respiratory syncytial virus neutralization by motavizumab", NATURE STRUCTURAL BIOL, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 17, no. 2, doi:10.1038/NSMB.1723, ISSN 1072-8368, (20100201), page 248, (20100124), XP009133396 [YP] 1-9 * page 250, column l, paragraph 4 *
SEARCH- BEGONA RUIZ-ARGUELLO M ET AL, "Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanism", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, (20040101), vol. 85, doi:10.1099/VIR.0.80318-0, ISSN 0022-1317, pages 3677 - 3687, XP007917291 [A] 1-9 * figures 1-3 *
SEARCH- SISSOËFF LUDMILLA ET AL, "Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, (20050901), vol. 86, no. Pt 9, doi:10.1099/VIR.0.81063-0, ISSN 0022-1317, pages 2543 - 2552, XP002426506 [Y] 1-9 * figure 1; table 1 *
SEARCH- DIANA MART N ET AL, "Sequence elements of the fusion peptide of human respiratory syncytial virus fusion protein required for activity", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, (20060101), vol. 87, doi:10.1099/VIR.0.81715-0, ISSN 0022-1317, pages 1649 - 1658, XP002600413 [A] 1-9 * figures 6,7 *
SEARCH- VALARCHER J -F ET AL, "Bovine respiratory syncytial virus lacking the virokinin or with a mutation in furin cleavage site RA(R/K)R-109 induces less pulmonary inflammation without impeding the induction of protective immunity in calves", JOURNAL OF GENERAL VIROLOGY, (200606), vol. 87, no. Part 6, ISSN 0022-1317, pages 1659 - 1667, XP008136764 [A] 1-9 * figures 1-3; tables 1,2 *
SEARCH- J. S. MCLELLAN ET AL, "Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus", SCIENCE, (20131101), vol. 342, no. 6158, doi:10.1126/science.1243283, ISSN 0036-8075, pages 592 - 598, XP055391357 [T] 1-9 * the whole document *
SEARCH- J. S. MCLELLAN ET AL, "Supplementary Materials for Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus", SCIENCE, (20131031), doi:10.1126/science.1243283, ISSN 0036-8075, pages 1 - 30, XP055364874 [T] 1-9 * the whole document *
SEARCH- ALAN RIGTER ET AL, "A Protective and Safe Intranasal RSV Vaccine Based on a Recombinant Prefusion-Like Form of the F Protein Bound to Bacterium-Like Particles", vol. 8, no. 8, doi:10.1371/JOURNAL.PONE.0071072, ISSN 1932-6203, (20130801), pages e41072.1 - e41072.14, PLOS ONE, PUBLIC LIBRARY OF SCIENCE, URL: http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0071072&representation=PDF, (20130812), XP002718926 [T] 1-9 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents